US Wound Dressing Market Valued at $693.6 million in 2025, Set to Grow at a 5.8% CAGR

US wound dressing market was valued at $4,912.9 million in 2025 and is projected to reach $7,599.7 million by 2035, growing at a CAGR of 4.1% during the forecast period (2026-2035). Regulatory changes from the FDA, including proposed reclassification of certain wound dressings and liquid wound washes, create clearer pathways for unclassified products, enhancing market confidence and driving innovation and growth among manufacturers and investors. For instance, in February 2024, the FDA proposed reclassifying certain wound dressings and liquid wound washes containing antimicrobials or chemicals as Class II or III devices. This change required compliance with 510(k) for Class II products and a premarket approval (PMA) for Class III products. Class II manufacturers have six months to meet new controls, while Class III manufacturers can file a PMA notice within 90 days, with a 30-month approval timeline. The reclassification affects previously unclassified solid, gel-based dressings and liquid washes.

Browse the full report description of “US Wound Dressing Market Size, Share & Trends Analysis Report by Type (Advanced Wound Dressing and Traditional Wound Dressing), by Application (Burn, Ulcer, Surgical Wound, and Traumatic Wound), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/us-wound-dressing-market

FDA Clearance and Approvals Driving Wound Care Innovation

• In May 2025, the FDA approved prademagene zamikeracel cellular sheets (Zevaskyn) and updated the label for Vyjuvek to allow broader use (including at home) in patients with dystrophic epidermolysis bullosa (DEB), a rare genetic condition that causes chronic wounds.
• In October 2025, Krystal Biotech received approval to expand B?VEC (Vyjuvek) use to include DEB patients from birth and permit self?application, enhancing access and management of wounds at home.
• In October 2024, the US FDA granted 510(k) clearance for Microlyte Ag/Lidocaine, the first antimicrobial wound dressing that combines silver (for antimicrobial action) with lidocaine (for local pain relief) to manage painful wounds such as ulcers, burns, and surgical wounds.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
• Competitive Landscape - B. Braun Melsungen AG, Coloplast Group, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, PAUL HARTMANN AG

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US Wound Dressing Market Report Segment

By Type

• Advanced Wound Dressing
  • Alginates Dressing
  • Collagen Dressing
  • Hydrocolloids Dressing
  • Hydrogels Dressing
  • Other Dressing
• Traditional Wound Dressing
  • Gauze
  • Lint
  • Wadding
  • Plasters
  • Others

By Application

• Burn
• Ulcer
  • Diabetic Foot Ulcer
  • Pressure Ulcer
  • Venous Ulcer
• Surgical Wound
• Traumatic Wound

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-wound-dressing-market